TOKYO (Reuters) - U.S. private equity firm Bain Capital said it may withdraw its tender offer proposal for Japanese IT firm ...

The Australia-based startup gets seed funding to enhance product management tools, facilitating idea tracking and roadmap ...

Bain Capital is considering withdrawing its tender offer for Japanese IT firm Fuji Soft after rival U.S. private equity giant ...

Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...

TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ...

Independent company plans significant investment in innovation, both internal product development and external licensing and acquisitions, supported by Bain Capital investment Founded in 1678 ...

Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is acquiring Mitsubishi Tanabe Pharma Corporation in a multi-billion ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes and cancer with “precision medicine”. Leverage the power of TipRanks ...

Boston-based Bain Capital hired a JLL senior leader as its head of real estate capital markets. Keith Largay has taken the role at the investment firm, Bain announced in a LinkedIn post.

Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit, adding to a dealmaking boom in Japan. The deal values Mitsubishi Tanabe Pharma at about ¥510 ...